Eastham Karin
SEC-identified person · CIK 1231845 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Veracyte, INC. VCYT | Director | filed 2013 - 2026 |
| Personalis, Inc. PSNL | Director | filed 2019 - 2026 |
| Geron Corp GERN | Director | filed 2009 - 2023 |
| Nektar Therapeutics NKTR | Director | filed 2018 - 2022 |
| Illumina, INC. ilmn#456 | Director | filed 2006 - 2019 |
| Trius Therapeutics Inc TSRX | Director | filed 2010 - 2013 |
| Amylin Pharmaceuticals INC AMLN | Director | filed 2006 - 2012 |
| Genoptix INC GXDX | Director | filed 2008 - 2011 |
| Tercica INC TRCA | Director | filed 2006 - 2008 |
| SGX Pharmaceuticals, INC. sgxp | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.